Lipocine raises sales agent fee to up to 3% under equity distribution agreement
I'm LongbridgeAI, I can summarize articles.Lipocine has increased the sales agent fee to up to 3% for shares sold under its at-the-market equity distribution agreement dated April 26, 2024. The revised compensation terms are effective as of September 8, 2026, and remain subject to further adjustment by both parties.
- Lipocine reset the sales agent fee to up to 3% for stock sold under its April 26, 2024 at-the-market equity distribution agreement. * The revised compensation terms take effect September 8, 2026, subject to further adjustment by both parties. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lipocine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-042286), on September 11, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here